"
Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 35: | Line 35: | ||
!align="center"|[[Team:SupBiotech-Paris/Equipe#drapeau|Équipe]] | !align="center"|[[Team:SupBiotech-Paris/Equipe#drapeau|Équipe]] | ||
!align="center"|[[Team:SupBiotech-Paris/Gestion de projet#drapeau|Gestion de projet]] | !align="center"|[[Team:SupBiotech-Paris/Gestion de projet#drapeau|Gestion de projet]] | ||
| - | !align="center"|[[Team:SupBiotech-Paris/MediaFr#drapeau| | + | !align="center"|[[Team:SupBiotech-Paris/MediaFr#drapeau|Galerie]] |
!align="center"|[[Team:SupBiotech-Paris/Remerciement#drapeau|Remerciements]] | !align="center"|[[Team:SupBiotech-Paris/Remerciement#drapeau|Remerciements]] | ||
|} | |} | ||
Revision as of 14:35, 15 October 2009
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Ciblage Cellulaire Cancer Conclusion
Ressources
Biobricks Matériel & Méthode Bibliographie
Ethique & sûreté
